Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brincidofovir vs Cidofovir for Adenovirus Infection after Allo-HCT
NCT07387367Phase 3Recruiting
- Sponsor
- SymBio Pharmaceuticals
- Start
- Mar 2026
- Primary completion
- Jan 2028
- Modality
- Metabolically Activated Prodrugs
- Countries
- 13
01
Overview
A Phase 3 trial of brincidofovir in adenovirus infection, sponsored by SymBio Pharmaceuticals. Started Mar 2026; status: recruiting.
02
Drugs
brincidofovir
03
Conditions
adenovirus infection
Beyond the preview
Go deeper on NCT07387367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07387367.